The funding will enable clinical development of Ciloa’s candidate APN-sEV (Adiponectin associated with exosomes) up to phase IIa in type 2 diabetes and obesity, and the implementation of large-scale ...

It’s been a fast-paced week in the world of startups and tech innovation, with news flying in from all corners — funding rounds, strategic partnerships, ...

This review explores the potential of punicic acid in pomegranate seed oil as a nutraceutical for cardiovascular health.

Obesity is defined by chronic low-grade inflammation in the body. Fat cells, particularly dysfunctional ones, release pro-inflammatory cytokines. This chronic inflammation causes harm to various ...

The field of obesity and metabolism in endocrine-related cancers is gaining significant attention due to the complex ...

Baseline BMI may play a significant role in improving exercise capacity, body weight and BP among patients with HF with ...

Obesity-related cancer deaths in the U.S. have tripled in just two decades, with women, older adults, and minority groups ...

Stopping anti-obesity medications leads to significant weight regain, starting as early as eight weeks and stabilizing by six ...

Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

A new study reports that GLP-1 medications may improve low testosterone in men with obesity or type 2 diabetes. The findings ...

The first human-tested weight-loss drug that burns calories through creatine-based heat generation, without reducing appetite, has successfully completed its Phase I trial.